In the article that accompanies this editorial, Rahman et al 2 describe the results from the first three experimental arms of the INSIGhT trial which, to our knowledge, is the first adaptive platform ...

This approach, called Bayesian Adaptive Randomization, reduces the number of patients exposed to therapies that are unlikely to be successful.

Covariate-adaptive randomization represents an advanced methodology in the design of clinical trials, ensuring a balanced distribution of prognostic factors among treatment groups.

Berry Consultants, LLC announced today that FACTS 7 was released to existing users and is now available to all new clients. FACTS (Fixed and Adaptive ...

This approach, called Bayesian Adaptive Randomization, reduces the number of patients exposed to therapies that are unlikely to be successful.

GBM AGILE is a patient-centric clinical trial that uses adaptive randomization to dynamically adjust how treatments are assigned to patients.

The decision of how to allocate subjects to treatment groups is of great importance in experimental clinical trials for novel investigational drugs, a multibillion-dollar industry. Statistical power, ...

We used Bayesian response-adaptive randomization 7,8 to concurrently study five regimens containing different combinations of these drugs with the goal of identifying multiple alternatives that ...

The study used a response-adaptive randomization design, where the randomization switches from a drug that doesn't appear to have a chance of working to the arm more likely to be beneficial.

Global Coalition for Adaptive Research (GCAR) is a 501 (c) (3) non-profit corporation uniting physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma companies ...

Bayesian Adaptive Randomization: Full of Promise With a Helping of Caution The following represents disclosure information provided by the authors of this manuscript. All relationships are considered ...